Clinical Trial Update: A Phase I First-in-Human Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of SWA1211 Tablets in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This document describes a Phase I first-in-human, open-label trial evaluating safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of SWA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• SWA1211

Snippet

Sponsor: Beijing StoneWise Technology Co., Ltd | Conditions: Solid Tumor Malignancies | Phase 1 | Status: RECRUITING